Impotens forarsaget af behandling med methotrexat

Ida Elisabeth Irene Penninga; H.K. Larsen; S.E. Andersen

Impotens forarsaget af behandling med methotrexat

Ida Elisabeth Irene Penninga, H.K. Larsen, S.E. Andersen

5 Citations (Scopus)

Abstract

Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58 year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence nine months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously
Udgivelsesdato: 2008/1/28

Original language	Danish
Journal	Ugeskrift for læger
Volume	170
Issue number	5
Pages (from-to)	354-
ISSN	0041-5782
Publication status	Published - 2008

Cite this

@article{7d170ed08d6511de8bc9000ea68e967b,

title = "Impotens forarsaget af behandling med methotrexat",

abstract = "Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58 year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence nine months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously Udgivelsesdato: 2008/1/28",

author = "Penninga, {Ida Elisabeth Irene} and H.K. Larsen and S.E. Andersen",

year = "2008",

language = "Dansk",

volume = "170",

pages = "354--",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "5",

}

TY - JOUR

T1 - Impotens forarsaget af behandling med methotrexat

AU - Penninga, Ida Elisabeth Irene

AU - Larsen, H.K.

AU - Andersen, S.E.

PY - 2008

Y1 - 2008

N2 - Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58 year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence nine months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously Udgivelsesdato: 2008/1/28

AB - Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58 year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence nine months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously Udgivelsesdato: 2008/1/28

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 170

SP - 354-

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 5

ER -